Header-Bild für Robotic Summit 2025
Profilbild für Rewiring the Nervous System: A Personalized Approach to Spinal Cord Injury

Rewiring the Nervous System: A Personalized Approach to Spinal Cord Injury

Donnerstag, 20. November 2025 16:30 - 16:50 CET Plenum

ReferentIn: Gil Hakim

tba

RednerInnen

Profilbild für Gil Hakim

Gil Hakim ReferentIn

CEO

Gil Hakim is a biotech executive with 20+ years of experience in early-stage innovation and clinical strategy. As former CEO of UroGen Pharma (NASDAQ: URGN), he led its growth from concept to a public biotech unicorn. Now CEO of Matricelf, Gil is advancing autologous neural tissue implants to restore function in spinal cord injury. His work connects regenerative medicine with cutting-edge health technologies, aligning with the summit’s focus on tech-driven medical innovation.